SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DavidCG who wrote (555)7/10/1998 2:09:00 PM
From: Graham Marshman  Read Replies (1) of 4028
 
So, based on latest I hear from CSI, the order of some actions has changed based on the large potential antisense market. Telovector basically comes in two parts, rocket (the delivery vector) and warhead ( the telomere sequence.) Both of these are obviously needed for animal studies.

Focus now is on the delivery vector first, which will then have application via licensing to general antisense community. They pay the FDA toll, CSI picks up a good share of revenue and gets the technology approved for free. (potential $330M market in 2000 and growing.)

Second step will be the CSI warhead development, animal testing etc.

First thoughts on this are:

Pro: Antisense delivery is a large and fast growing market space with little visible competition. Best shot for earliest revenues at least expense and should generate good margins. Gets a good portion of the warhead work done on someone elses buck. Establishes CSI as the brand name for gene therapy delivery.

Con: Gee, I really want to cure cancer and aging! Delivery could be driven towards a commodity business if competitive means are developed after a few years unless CSI can somehow get a Microsoft type lock on the market.

Still pondering........

Graham
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News